Company: FTII
Filing Date: 2025-02-14
Form Type: S-4
Source: 0001493152-25-006997
Chunk: 640

Company: FutureTech II Acquisition Corp.
Filing Date: 2025-02-14
Form: S-4
Chunk 640
---
, INC.

NOTES TO FINANCIAL STATEMENTS</div>

There were no stock options granted or exercised under the 2015 Plan during the years ended December 31, 2023 and 2022.

A summary of options outstanding under the plans as of December 31, 2023 and activity during the year then ended is presented below:

|                                |     | Year Ended December 31, 2023 |         |     |                                 |      |     |                                                     |      |     |                           |           |
|:-------------------------------|:----|:-----------------------------|--------:|:----|:--------------------------------|-----:|:----|:----------------------------------------------------|-----:|:----|:--------------------------|----------:|
|                                |     | Number of Options            |         |     | Weighted Average Exercise Price |      |     | Weighted Average Remaining Contractual Term (Years) |      |     | Aggregate Intrinsic Value |           |
| Outstanding, beginning of year |     |                              | 523,552 |     | $                               | 1.52 |     |                                                     |      |     |                           |           |
| Granted                        |     |                              |       - |     |                                 |    - |     |                                                     |      |     |                           |           |
| Exercised                      |     |                              |       - |     |                                 |    - |     |                                                     |      |     |                           |           |
| Forfeit                        |     |                              |       - |     |                                 |    - |     |                                                     |      |     |                           |           |
| Outstanding, end of year       |     |                              | 523,552 |     | $                               | 1.52 |     |                                                     | 2.95 |     | $                         | 3,573,119 |

Of the total options outstanding as of December 31, 2023, there were 523,552 vested options with a weighted average exercise price of $1.52 per share, a weighted average remaining contractual life of 2.95 years and an aggregate intrinsic value of $3,573,119. The total fair value of options vested during the years ended December 31, 2023 and 2022 was $34,048 and $177,162, respectively.

Stock-based compensation expense is recorded as either research and development or general and administrative expense as presented in the statement of operations based on the employee or consultant classification. Stock-based compensation expense was recognized in the